Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Inventory: 2018-2025

Historic Inventory for Agios Pharmaceuticals (AGIO) over the last 6 years, with Sep 2025 value amounting to $32.0 million.

  • Agios Pharmaceuticals' Inventory rose 21.21% to $32.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.0 million, marking a year-over-year increase of 21.21%. This contributed to the annual value of $27.6 million for FY2024, which is 44.77% up from last year.
  • Agios Pharmaceuticals' Inventory amounted to $32.0 million in Q3 2025, which was up 3.84% from $30.8 million recorded in Q2 2025.
  • Agios Pharmaceuticals' Inventory's 5-year high stood at $32.0 million during Q3 2025, with a 5-year trough of $2.5 million in Q1 2022.
  • For the 3-year period, Agios Pharmaceuticals' Inventory averaged around $23.4 million, with its median value being $23.9 million (2024).
  • Data for Agios Pharmaceuticals' Inventory shows a peak YoY spiked of 357.71% (in 2023) over the last 5 years.
  • Agios Pharmaceuticals' Inventory (Quarterly) stood at $8.5 million in 2022, then surged by 124.63% to $19.1 million in 2023, then surged by 44.77% to $27.6 million in 2024, then grew by 21.21% to $32.0 million in 2025.
  • Its last three reported values are $32.0 million in Q3 2025, $30.8 million for Q2 2025, and $29.6 million during Q1 2025.